CH
Christopher G. Hayes
Chief Legal Officer

Christopher G. Hayes insider trades: Verrica Pharmaceuticals (VRCA) stock buys and sales

Chief Legal Officer, Verrica Pharmaceuticals Last trade Mar 17, 2025 15 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2021
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christopher reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 17, 2025VRCA↓ Sell$3K
Aug 27, 2024VRCA↓ Sell$93K
Jul 23, 2024VRCA↓ Sell$153K
Nov 15, 2023VRCA↓ Sell$99K
Jul 24, 2023VRCA↓ Sell$163K
Jul 11, 2022VRCA↑ Buy$26K
Jul 5, 2022VRCA↑ Buy$12K
Jun 4, 2021VRCA↑ Buy$24K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VRCA insiders

Open-market trades in the last 12 months

About Christopher G. Hayes's insider trades

Christopher G. Hayes is Chief Legal Officer at Verrica Pharmaceuticals (VRCA). Since Jun 4, 2021, Christopher has reported 3 open-market purchases worth $62K and 5 sales worth $512K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.